
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark is a leading manufacturer in the tissue and hygiene market, with over half of its sales from personal care products and approximately one-third from consumer tissue products. The company anticipates a robust innovation pipeline for 2026, indicating a focus on enhancing product offerings through advanced technology, which can help maintain competitiveness in a dynamic market. With a strong geographical sales distribution that includes over half in North America and a strategic expansion into Kenvue's consumer health portfolio slated for 2026, Kimberly-Clark positions itself for sustainable growth and increased market share.
Bears say
Kimberly-Clark is experiencing a concerning organic sales decline, with estimates indicating a drop of -4.0% for 3Q25 in North America, a significant decrease compared to prior expectations of +4.5%. Additionally, the company's measured retail sales in the U.S. have declined by -2.7% during the third quarter of 2025 to date, reflecting ongoing challenges in the consumer market. Furthermore, financial projections have been revised downward, with estimated earnings per share for fiscal 2025 decreasing from $7.60 to $7.41 and for 2026 from $8.00 to $7.85, underscoring a negative outlook for profitability.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares